Homozygote x Homozygote [or Crossing to C57BL/6JJcl] Homozygote x Homozygote [or Crossing to C57BL/6JJcl] Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="https://www.bioreg.kyushu-u.ac.jp/saibou/index_en.html" target="_blank">Lab HP</A> B6;129P2-Fbxl3<tm1Kei> B6;129P2-Fbxl3<tm1Kei> Fluorescent Proteins/lacZ System 中山 敬一 true Fbxl3 gene knockout mice. Exons 2 and 3 were replaced with an IRES-lacZ/neo cassette. Metabolism Research 条件を付加する。利用者は提供承諾書を用いて、事前に寄託者の承諾を得る。<br>共同研究。 D (more than 6 months) D(6か月以上) E14 [129P2/OlaHsd] 九州大学生体防御医学研究所・中山敬一先生。E14 ES細胞を用いて作出。C57BL/6Jへ交配された(N7世代)。 Keiichi NAKAYAMA E. coli Neomycin resistance gene, mouse phosphoglycerate kinase promoter, SV40 polyA signal, ECMV internal ribosomal entry site (ires), E. coli lacZ, phage P1 loxP Developed by Keiichi Nakayama, Medical Institute of Bioregulation, Kyushu University. E14 ES cells were used. The mutant mice were crossed to C57BL/6J (N7 generations). Fbxl3遺伝子のノックアウトマウス。エクソン2と3をIRES-lacZ/neoカセットで置換。Fbxl3はSCF型ユビキチンリガーゼSCF<Fbxl3>のF-boxタンパク質サブユニットである。SCF<Fbxl3>は概日時計中枢において中心的な役割を果たすCRYタンパク質のユビキチン化依存的分解に関わっており、Fbxl3遺伝子の機能を阻害すると、恒暗条件下での概日リズムの延長を呈する。 Cre/loxP system RBRC06389 Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. The RECIPIENT agrees to use this BIOLOGICAL RESOURCE as a collaboration with the DEPOSITOR. Fbxl3 KO, B6-Fbxl3 KO Fbxl3 KO, B6-Fbxl3 KO